Accessibility Menu
Bonesupport Ab (publ) logo

Bonesupport Ab (publ)(OM) BONEX

Market CapSEK 14.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+614%
5 Year+174%
1 Year-30%
1 Month-1%
SEK 218.60
-4.37%
-10.00Today
Bonesupport Ab (publ) last closing stock price
MetricPriceDate
Last closeSEK 218.602026-08-31
Bonesupport Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.27%SEK 219.202026-08-24
1 month-0.73%SEK 220.202026-07-31
3 month-2.41%SEK 224.002026-06-02
Year to date+16.28%SEK 188.002025-12-30
1 year-29.57%SEK 310.402025-08-29
3 year+73.08%SEK 126.302023-09-01
5 year+174.28%SEK 79.702021-09-01
Since inception+614.38%SEK 32.002017-06-21

Bonesupport Ab (publ) Financials at a Glance

Market Cap

SEK 14.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.29B

Net Income (TTM)

SEK 213.91M

EPS (TTM)

SEK 3.20

P/E Ratio

70.38

Dividend

SEK 0.00

Beta (Volatility)

0.88 (Low)

Price

SEK 218.60

Volume

207,509

Open

SEK 221.00

Previous Close

SEK 228.60

Daily Range

SEK 218.60 - SEK 221.40

52-Week Range

SEK 165.00 - SEK 323.00

Estimated Earnings Date

Oct 22, 2026

BONEX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bonesupport Ab (publ)

Bonesupport Holding AB (publ) is an innovative orthobiologics company focused on developing and commercializing injectable bioceramic bone graft substitutes. These products are designed to treat bone voids and are marketed internationally, including in Europe and North America.

Products and Services
  • CERAMENT Bone Void Filler, a synthetic injectable solution
  • CERAMENT G, infused with gentamicin for enhanced healing
  • CERAMENT V, containing vancomycin for infection control
Growth Outlook
  • Revenue increased to SEK 355.7 million in Q2 2026
  • Operating income margin improved to 25.2% in Q2 2026
  • Strong cash flow generation supports ongoing R&D initiatives
Financial Highlights
  • Net income of SEK 81.9 million reported in Q2 2026
  • Gross profit margin maintained at 90.8% in Q2 2026
  • Current ratio of 5.44 indicates strong liquidity position
Bonesupport Holding AB (publ) has established itself as a leader in the orthobiologics sector, with a strong focus on innovative solutions for bone regeneration. The company's flagship products, such as CERAMENT, are designed to address critical needs in orthopedic and trauma surgery, providing effective solutions for patients with bone voids. The recent financial performance indicates robust growth, with significant revenue increases and strong profit margins, reflecting the company's operational efficiency and market demand for its products. The solid liquidity position further enhances the company's ability to invest in research and development, paving the way for future innovations and expansion in the global market.
AI Generated • Aug 19, 2026

Industry

Biotechnology

Sector

Health Care

Employees

139

CEO

Torbjörn Sköld, MBA

Website

www.bonesupport.com

Headquarters

Lund, SN 223 70, SE

BONEX Financials

Key Financial Metrics (TTM)

Gross Margin

92.05%

Operating Margin

24.28%

Net Income Margin

16.63%

Return on Equity

23.82%

Return on Capital

31.48%

Return on Assets

19.10%

Earnings Yield

1.42%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

SEK 14.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

65.49M

Volume

207.51K

Avg. Volume

209.05K

Financials (TTM)

Gross Profit

SEK 1.18B

Operating Income

SEK 312.31M

EBITDA

SEK 319.35M

Operating Cash Flow

SEK 266.86M

Capital Expenditure

-SEK 4.31M

Free Cash Flow

SEK 262.55M

Cash & ST Invst.

SEK 434.31M

Total Debt

SEK 10.13M

Bonesupport Ab (publ) Performance Analysis

Bonesupport Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 328,818,00054.5%
20232023-12-31SEK 591,077,00079.8%
20242024-12-31SEK 898,727,00052.0%
20252025-12-31SEK 1,174,661,00030.7%
Bonesupport Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-303.4%
Q42025-12-316.3%
Q12026-03-313.7%
Q22026-06-309.8%
Bonesupport Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -1.06-20.9%
20232023-12-31SEK 3.74N/A
20242024-12-31SEK 2.01-46.2%
20252025-12-31SEK 2.136.0%
Bonesupport Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-35.0%
Q42025-12-3126.9%
Q12026-03-3121.2%
Q22026-06-3053.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 355.72M

+25.1%

Gross Profit

SEK 323.02M

+23.0%

Gross Margin

90.81%

N/A

Market Cap

SEK 14.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

SEK 87.54M

N/A

Employees

171

N/A

Net Income

SEK 81.88M

+54.3%

EBITDA

SEK 91.70M

+61.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 434.31M

+40.2%

Total Debt

SEK 10.13M

-20.1%

Accounts Receivable

SEK 221.71M

+16.4%

Inventory

SEK 167.56M

+26.6%

Long Term Debt

SEK 2.47M

-56.5%

Short Term Debt

SEK 7.66M

+9.3%

Return on Assets

19.10%

N/A

Return on Invested Capital

32.76%

N/A

Free Cash Flow

SEK 64.60M

+35.0%

Operating Cash Flow

SEK 67.09M

+34.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About BONEX

What is the current price of Bonesupport Ab (publ)?

Bonesupport Ab (publ) is trading at SEK 218.60 per share.

What is the 52-week range for Bonesupport Ab (publ)?

Over the past 52 weeks, Bonesupport Ab (publ) has traded between SEK 165.00 and SEK 323.00.

How much debt does Bonesupport Ab (publ) have?

As of the most recent reporting period, Bonesupport Ab (publ) reported total debt of SEK 10.13M.

How much cash does Bonesupport Ab (publ) have on hand?

Bonesupport Ab (publ) reported SEK 434.31M in cash and cash equivalents in its most recent financial results.

What is Bonesupport Ab (publ)’s dividend yield?

Bonesupport Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services